Fatal hepatic necrosis after isoflurane anaesthesia

Anaesthesia

Volumn 52, Issue 9, 1997, Pages 892-895

  Weitz, J ^a   Kienle, P ^a   Bohrer H ^a   Hofmann, W ^a   Theilmann, L ^a   Otto, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Anaesthetics, volatile; isoflurane; Complications; death; Liver; toxicity

Indexed keywords

ENFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE;

ADULT; ARTICLE; CASE REPORT; ETIOLOGY; FATALITY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LIVER FAILURE; LIVER NECROSIS; LIVER TOXICITY; SENSITIZATION;

EID: 0030934019     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.1997.187-az0319.x     Document Type: Article

References (17)

1. Stoelting RK. Isoflurane and postoperative hepatic dysfunction. Canadian Journal of Anaesthesia 1987; 34: 223-6.
2. Stoelting RK, Blitt CD, Cohen PJ, Merin RG. Hepatic dysfunction after isoflurane anesthesia. Anesthesia and Analgesia 1987; 66: 147-53.
3. Brunt EM, White H, Marsh JW, Holtmann B, Peters MG. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: a case report. Hepatology 1991; 13: 1017-21.
4. Carrigan TW, Staughen WJ. A report of hepatic necrosis and death following isoflurane anesthesia. Anesthesiology 1987; 67: 581-3.
5. Gregoire S, Smiley RK. Acute hepatitis in a patient with mild factor IX deficiency after anaesthesia with isoflurane. Canadian Medical Association Journal 1986; 135: 645-6.
6. Gunaratnam NT, Benson J, Gandolfi AJ, Chen M. Suspected isoflurane hepatitis in an obese patient with a history of halothane hepatitis. Anesthesiology 1995; 83: 1361-4.
7. Gunza JT, Pashayan AG. Postoperative elevation of serum transaminases following isoflurane anesthesia. Journal of Clinical Anesthesia 1992; 4: 336-41.
8. Scheider DM, Klygis LM, Tsang TK, Caughron MC. Hepatic dysfunction after repeated isoflurane administration. Journal of Clinical Gastroenterology 1993; 17: 168-70.
9. Ray DC, Drummond GB. Halothane hepatitis. British Journal of Anaesthesia 1991; 67: 84-99.
10. NeubergerJ, Kenna JG. Halothane hepatitis: a model of immune mediated drug hepatotoxicity. Clinical Science 1987; 72: 263-71.
11. Satch H, Gillette JR, Takemura T, et al. Investigation of the immunological basis of halothane-induced hepatotoxicity. Advances in Experimental Medicine and Biology 1986; 197: 657-73.
12. Zimmerman H. Even Isoflurane. Hepatology 1991; 13: 1251-3.
13. Zimmerman HJ. Anesthetic agents. In: Zimmerman HJ, ed. Hepatotoxicity: Adverse Effects of Drugs and Other Chemicals on the Liver. New York: Appleton-Century-Crofts, 1978: 370-94.
14. Eger EI, Smuckler EA, Ferrell LD, Goldsmith CH, Johnson BH. Is enflurane hepatotoxic? Anesthesia and Analgesia 1986; 65: 21-30.
15. Bird GL, Williams R. Detection of a halothane metabolite hapten in sera from patients with halothane-associated hepatitis. Journal of Hepatology 1989; 9: 366-73.
16. Martin JL, Kenna JG, Pohl LR. Antibody assays for the detection of patients sensitized to halothane. Anesthesia and Analgesia 1990; 70: 154-9.
17. Christ DD, Satoh H, Kenna JG, Pohl LR. Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane. Drug Metabolism and Disposition 1988; 16: 135-40.